BFM
GOSS icon

Boothbay Fund Management’s Gossamer Bio GOSS Stock Holding History

Boothbay Fund Management’s Portfolio GOSS Stock Details GOSS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-58,335
Closed -$53.2K – 1709
2023
Q4 		$53.2K Buy
+58,335
New +$43.1K ﹤0.01% 1517
2022
Q4 		– Sell
-86,541
Closed -$1.04M – 2165
2022
Q3 		$1.04M Sell
86,541
-16,425
-16% -$204K 0.03% 851
2022
Q2 		$862K Buy
102,966
+30,466
+42% +$236K 0.02% 888
2022
Q1 		$629K Sell
72,500
-43,899
-38% -$423K 0.01% 1173
2021
Q4 		$1.32M Sell
116,399
-17,676
-13% -$210K 0.03% 636
2021
Q3 		$1.69M Buy
134,075
+31,455
+31% +$290K 0.05% 517
2021
Q2 		$833K Buy
102,620
+2,165
+2% +$18.8K 0.03% 783
2021
Q1 		$929K Hold
100,455
– – 0.03% 635
2020
Q4 		$971K Buy
100,455
+51,439
+105% +$507K 0.04% 503
2020
Q3 		$608K Sell
49,016
-10,707
-18% -$142K 0.04% 594
2020
Q2 		$776K Buy
+59,723
New +$751K 0.05% 456
2019
Q2 		– Sell
-13,019
Closed -$282K – 794
2019
Q1 		$282K Buy
+13,019
New +$271K 0.03% 519

Other funds holding GOSS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
KCM
Kalehua Capital Management Dallas, Texas $141M AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return

Boothbay Fund Management's GOSS Position: Q1 2024 in Review

Boothbay Fund Management sold out of Gossamer Bio (GOSS) in Q1 2024, closing a stake of 58,335 shares — an estimated $53.2K sold.

Boothbay Fund Management first reported a position in GOSS in Q1 2019 and held it in 12 quarters. The position peaked at $1.69M in Q3 2021. 110 funds tracked by Wall St. Rank hold GOSS as of Q1 2024.

  • Boothbay Fund Management reported no remaining Gossamer Bio position as of Q1 2024 after selling out during the quarter.
  • Boothbay Fund Management sold 58,335 Gossamer Bio shares in Q1 2024, an estimated $53.2K.
  • Boothbay Fund Management first reported a position in Gossamer Bio in Q1 2019 and held it in 12 quarters.
  • Boothbay Fund Management's Gossamer Bio position peaked at $1.69M in Q3 2021.
  • 110 funds tracked by Wall St. Rank held Gossamer Bio as of Q1 2024.

Based on Boothbay Fund Management's 13F filing for Q1 2024, filed 15 May 2024.